Wholesale:ripples made by Pfizer

摘要

Pfizer's decision to allow its medicines to be supplied by a single distributor only (UniChem) has stung the pharmacy sector (PJ,1 October 2006,p413).Criticism has come from all quarters - wholesalers,pharmacists and the organisations that represent them,and from others who have an interest in the movement of medicines across the EU and the wider global market.There are concerns that this scheme,direct to pharmacy using a single distributor,undermines both the ability of community pharmacy to do its job and the supply chain."Since Pfizer's solus distribution model was implemented in March,several surveys of community pharmacists have taken place and each one has demonstrated that this particular model has created problems for community pharmacy," says Steve Dunn,group managing director of AAH Pharmaceuticals.